teclistamab
genmab,janssen
['tecvayli', 'multiple myeloma', '$jnj', 'janssen']
janssen's tecvayli shows sustained efficacy and safety in treating relapsed or refractory multiple myeloma, with nearly 50% of patients achieving complete response. $jnj #asco2023 #positive 
Real-time news analysis & sentiment scoring for the stocks in the S&P500
Powered by @streetbeat_com of @gptnewstracker
Disclosure: https://t.co/sjkSk4W05p